Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: update after 40-year follow-up

D Huo, D Anderson, JR Palmer, AL Herbst - Gynecologic Oncology, 2017 - Elsevier
Objective Women exposed to diethylstilbestrol (DES) in utero are at increased risk for the
development of vaginal and cervical clear cell adenocarcinoma (CCA) at younger age. It is …

Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up

D Huo, D Anderson, JR Palmer… - Gynecologic …, 2017 - pubmed.ncbi.nlm.nih.gov
Objective Women exposed to diethylstilbestrol (DES) in utero are at increased risk for the
development of vaginal and cervical clear cell adenocarcinoma (CCA) at younger age. It is …

Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.

D Huo, D Anderson, JR Palmer, AL Herbst - Gynecologic Oncology, 2017 - europepmc.org
Objective Women exposed to diethylstilbestrol (DES) in utero are at increased risk for the
development of vaginal and cervical clear cell adenocarcinoma (CCA) at younger age. It is …

Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up

D Huo, D Anderson, JR Palmer… - Gynecologic …, 2017 - gynecologiconcology-online.net
Objective Women exposed to diethylstilbestrol (DES) in utero are at increased risk for the
development of vaginal and cervical clear cell adenocarcinoma (CCA) at younger age. It is …

[引用][C] Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up

D Huo, D Anderson, JR Palmer, AL Herbst - Gynecologic Oncology, 2017 - cir.nii.ac.jp
Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina
and cervix: Update after 40-year follow-up | CiNii Research CiNii 国立情報学研究所 学術情報 …